Objectives. We have previously investigated an association between the genome copy number variation (CNV) and
The periacetabular osteotomy (PAO) is a well-described procedure for symptomatic
Finite element analysis (FEA) has been applied for the biomechanical analysis of
Aims. The aim of the current study was to assess the reliability of the Ottawa classification for symptomatic
Introduction.
Aims. Radiological residual
Hip dysplasia has traditionally been classified based on the lateral centre edge angle (LCEA). A recent meta-analysis demonstrated no definite consensus and a significant heterogeneity in LCEA values used in various studies to define hip dysplasia and borderline dysplasia. To overcome the shortcomings of classifying hip dysplasia based on just LCEA, a comprehensive classification for adult
Background. Hip dysplasia has traditionally been classified based on the lateral center edge angle (LCEA). A recent meta-analysis demonstrated no definite consensus and a significant heterogeneity in LCEA values used in various studies to define hip dysplasia and borderline dysplasia. To overcome the shortcomings of classifying hip dysplasia based on just LCEA, a comprehensive classification for adult
It is generally agreed that in
Background: Hip dysplasia is a complex developmental process. Untreated
Introduction.
The purpose of this study was to examine a cohort of patients with minor
To investigate the proportion of dysplastic hips which are retroverted. We studied the radiographs of over seven hundred patients with dysplastic hips who had had a periacetabular osteotomy in the period 1984–1998. We excluded patients with neuromuscular dysplasia, Perthes’ disease of the hip, post-traumatic dysplasia and proximal focal femoral deficiency. We selected 232 radiographs of patients with congenital
Introduction: Persistent
Purpose. Patients with
Introduction.
For the treatment of the
Introduction: We performed cementless total hip arthroplasty (THA) with autogenous bone block grafting on 18 hips in 15 patients with marked
The
Management of symptomatic residual